The hypoglycemic effects of Juglans regia L. internal septum in type 2 diabetic patients: A double-blind, randomized, placebo-controlled clinical trial.
Fatemeh AfraArman ZargaranNooshin ShirzadMahboobeh HemmatabadiMahbube EbrahimpurMehrdad KarimiMahnaz KhanaviMehrzad MirshekariSoha NamaziPublished in: Journal of cardiovascular and thoracic research (2023)
has no significant effect on HbA1c, FBS, and insulin resistance. Moreover, no specific adverse reaction was observed in any of the patients.
Keyphrases
- double blind
- placebo controlled
- clinical trial
- insulin resistance
- phase ii
- end stage renal disease
- phase iii
- open label
- newly diagnosed
- ejection fraction
- chronic kidney disease
- adipose tissue
- peritoneal dialysis
- type diabetes
- metabolic syndrome
- prognostic factors
- randomized controlled trial
- high fat diet
- phase ii study
- weight loss
- electronic health record